Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL
Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL
Active, not recruiting · NCT05641428 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, histiocytosis, interdigitating dendritic cell sarcoma, lymphatic system disorder, malignant histiocytosis, neoplasm, non-Hodgkin lymphoma | Active, not recruiting | Phase 2 | 2026-10-05 | NCT05641428 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 27 |
| University Medical Center Groningen | 213 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NL-Amsterdam-AMC | Amsterdam | Netherlands | 10 |
| NL-Groningen-UMCG | Groningen | Netherlands | 17 |
| NL-Leiden-LUMC | Leiden | Netherlands | 9 |
| NL-Maastricht-MUMC | Maastricht | Netherlands | 13 |
| NL-Nijmegen-RADBOUDUMC | Nijmegen | Netherlands | 11 |
| NL-Rotterdam-ERASMUSMC | Rotterdam | Netherlands | 14 |
| NL-Utrecht-UMCUTRECHT | Utrecht | Netherlands | 16 |